D-0516-2016 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0516-2016 was initiated by RemedyRepack Inc. on Nov 11, 2015 and is designated Class II. Reason for recall: Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions. The recall status is terminated (terminated Nov 1, 2016). Affected quantity: 106 Vials.

Recall details

Product Type
Drugs
Report Date
Dec 16, 2015
Initiation Date
Nov 11, 2015
Termination Date
Nov 1, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
106 Vials

Product description

Novolin 70/30, 100 Units/mL Solu., Qty: 1 Vial, MFG by: Novo Nordisk, A/S, Bagsvaerd, Denmark DK-2880, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 52125-0414-01

Reason for recall

Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.

Distribution pattern

Nationwide

Code information

LOT#:QM114CZF0496, Exp 01/2016; B0025373-050514, B0029738-060914, Exp 02/2016; B0029737-060914, Exp 03/2016.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0516-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0516-2016. Report a data issue: hello@regdatalab.com.